This report was first published by Endpoints News. To see the original version, click here
The US International Trade Commission is opening an investigation into China’s support for biotech as well as the country’s pricing practices, looking at whether the government there “manipulated markets and disadvantaged American biotechnology firms.”
The trade commission’s role is mostly advisory, but the investigation was mandated by Congress in a recent spending bill, and could be a prelude to action by the Trump administration that could lead to restrictions on dealmaking or other policy measures meant to slow China’s industry.
您已阅读22%（627字），剩余78%（2232字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。